$ACI

Albertsons (ACI) Q2 2026 Earnings Call Transcript

Albertsons (ACI) reported Q2 2026 earnings with identical sales down 0.8%, adjusted EBITDA at $784M, and adjusted EPS at $0.36. Management acknowledged underperformance and outlined plans to cut costs, improve pricing, and streamline operations to boost shareholder value and customer experience. They aim to accelerate cost savings and focus on core markets and assets.

Original reporting
Published Oct 13, 2026, 11:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 12:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Albertsons (ACI) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ACIBearishMed
01

Why it matters

The earnings miss and guidance uncertainty may trigger a sell‑off, but the announced cost‑reduction program could be a catalyst for a later rebound.

02

Market read

First‑time disclosure of Q2 results for a large‑cap retailer; material for traders watching consumer stocks.

03

What to watch

Strong e‑commerce growth (11%) and pharmacy script count resilience may offset sales decline.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

Albertsons held its Q2 2026 earnings call, outlining operational challenges and cost‑saving plans.

Company-level read

Ticker impact

$ACIBearishMedium confidence
Context

Identical sales declined 0.8% and adjusted EPS was $0.36 per share, missing expectations.

Expected impact

downward pressure as investors price in weaker sales and earnings.

Evidence & confidence

The disclosed decline in sales and low EPS suggest earnings miss, which typically triggers sell‑offs.

Market effects

Grocery retail sector may face broader scrutiny over margin pressure.

U.S. consumer‑discretionary sentiment could soften.

Limited to U.S. retail investors; no global macro effect.

Counterpoint

If cost‑cutting initiatives accelerate, the stock could rebound despite short‑term miss.

Key entities

  • Albertsons Companies

    U.S. grocery retailer (ticker ACI).

  • Susan Morris

    CEO of Albertsons.

Related articles

$ACIMedAI 8/10

Grocer accuses Kroger of breaching obligations

Albertsons Cos is suing Kroger Co for over $9 billion, alleging breach of obligations in the failed $24.6 billion merger. The trial in Delaware Chancery Court will determine responsibility for the deal's collapse, blocked by a federal court in December 2024. Albertsons claims Kroger did not use 'best efforts' to secure regulatory approval.

$ACIMed

Albertsons Companies Inc (ACI) (Q2 2026) Earnings Call Highlights: Sales Dip, Cost Cuts Jump

Albertsons (ACI) reported Q2 sales dip, with CEO Susan Morris announcing a business review to focus on customer experience, financial performance, and cost cuts. Cost savings opportunities remain, with plans for more headcount reductions. Inflation is being managed, and pricing strategies are being refined market by market. The company is accelerating owned brands and centralizing buying to reduce costs. CapEx plans remain unchanged, focusing on high-return opportunities.

$ACIMed

How the former eBay and HP CEO plans to fix Albertsons

Albertsons reported a 0.8% drop in identical sales for Q2, with net sales at $18.9B. The company withdrew financial forecasts as it reviews strategy under new Executive Chairman Meg Whitman. Whitman, known for turnarounds at HP and eBay, suggested significant changes may be ahead. Albertsons faces challenges from food inflation and higher costs compared to rivals like Walmart and Kroger.

$ACIMedAI 8/10

Albertsons Presses Reset Button as Inflation Presses

Albertsons reported a 0.8% sales dip in Q3 and paused financial guidance amid a business review. CEO Susan Morris cited inflation and high fuel costs pressuring lower-income customers. The company plans to expand private-label offerings and refine pricing strategies. Digital engagement grew, with eCommerce and pharmacy customers driving loyalty. A refreshed strategy and financial roadmap are expected by Q4.